|
6,894
|
| 67374 |
Ghrelin
|
|
affects_activity of
|
cognition
|
|
|
27470930
|
Diabetes mellitus, type II
Insulin resistance
|
|
9,687
|
| 102338 |
ACE2
|
|
increases_quantity of
|
Alamandine
|
|
| 102339 |
ACE2
|
|
decreases_quantity of
|
Angiotensin A
|
|
|
23446738
|
Cardiovascular disease
|
|
11,717
|
| 116346 |
ACE2
|
|
decreases_quantity of
|
Angiotensin II
|
|
| 116348 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-7)
|
|
|
30404071
|
Diabetes mellitus, type II
Insulin resistance
|
|
11,748
|
| 116365 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-9)
|
|
| 116366 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
| 116369 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-7)
|
|
| 116370 |
ACE2
|
|
decreases_quantity of
|
Angiotensin II
|
|
|
32333398
|
COVID-19
|
|
11,776
|
| 116580 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
|
| 116581 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-9)
|
|
| 116588 |
ACE2
|
|
decreases_quantity of
|
Angiotensin II
|
|
| 116589 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-7)
|
|
|
23463883
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
|
11,823
|
| 116804 |
ACE2
|
|
decreases_quantity of
|
Angiotensin II
|
|
| 116809 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-7)
|
|
| 116812 |
ACE2
|
|
decreases_quantity of
|
Apelin-13
|
|
| 116814 |
ACE2
|
|
decreases_quantity of
|
Apelin-36
|
|
| 116846 |
ACE2
|
|
decreases_quantity of
|
Dynorphin A (1-13)
|
|
| 116849 |
ACE2
|
|
increases_quantity of
|
Dynorphin A (1-12)
|
|
| 116852 |
ACE2
|
|
decreases_quantity of
|
des-Arg9-bradykinin
|
|
| 116855 |
ACE2
|
|
decreases_quantity of
|
Neurotensin 1-8
|
|
| 116859 |
ACE2
|
|
decreases_quantity of
|
Angiotensin I
|
with low activity as for angiotensin II
|
|
11815627
|
Metabolic
|
|
12,035
|
| 118116 |
ACE2
|
|
decreases_quantity of
|
Angiotensin (1-7)
|
|
| 118117 |
ACE2
|
|
increases_quantity of
|
Alamandine
|
|
| 118118 |
Alamandine
|
|
increases_activity of
|
vasodilation
|
|
| 118119 |
Alamandine
|
|
decreases_activity of
|
fibrosis
|
|
| 118120 |
Alamandine
|
|
decreases_activity of
|
hypertension
|
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
|
12,056
|
| 118294 |
ACE2
|
NOT |
decreases_quantity of
|
Bradykinin
|
|
|
19065996
|
Diabetes mellitus, type II
Insulin resistance
|
|
12,110
|
| 118895 |
des-Arg9-bradykinin
|
|
increases_activity of
|
BDKRB1
|
in respiratory epithelium
|
| 118904 |
BDKRB1
|
|
increases_activity of
|
inflammatory response
|
in respiratory epithelium
|
|
28935640
|
Lung disease
|
|
12,111
|
| 118896 |
ACE2
|
|
decreases_quantity of
|
des-Arg9-bradykinin
|
in respiratory epithelium
|
|
28935640
|
Lung disease
|
|
12,178
|
| 119343 |
des-Arg9-bradykinin
|
|
increases_activity of
|
kallikrein-kinin system
|
|
| 119360 |
des-Arg9-bradykinin
|
|
increases_activity of
|
lung inflammation
|
|
| 119361 |
ACE2
|
|
decreases_quantity of
|
des-Arg9-bradykinin
|
|
| 119362 |
des-Arg9-bradykinin
|
|
increases_activity of
|
cytokine secretion
|
|
| 119363 |
des-Arg9-bradykinin
|
|
increases_activity of
|
inflammatory response
|
|
|
32544563
|
COVID-19
|
|
12,207
|
| 119852 |
ACE2
|
|
decreases_quantity of
|
Angiotensin II
|
|
| 119853 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-7)
|
|
| 119883 |
ACE2
|
|
decreases_quantity of
|
Apelin-13
|
|
| 119884 |
ACE2
|
|
decreases_quantity of
|
des-Arg9-bradykinin
|
|
| 119885 |
ACE2
|
|
decreases_quantity of
|
Neurotensin (1-13)
|
|
| 119886 |
ACE2
|
|
decreases_quantity of
|
beta-Casomorphin
|
|
| 119887 |
ACE2
|
|
decreases_quantity of
|
Dynorphin A (1-13)
|
|
| 119888 |
ACE2
|
|
decreases_quantity of
|
Ghrelin
|
|
|
32294179
|
Diabetes mellitus, type II
Insulin resistance
COVID-19
|
|
13,336
|
| 125938 |
Apelin-13
|
|
affects_activity of
|
inflammatory response
|
|
| 125939 |
Apelin-13
|
|
affects_activity of
|
histone acetylation
|
|
|
30181742
|
Chronic kidney disease
|
|
14,067
|
| 132942 |
ACE2
|
|
increases_quantity of
|
Alamandine
|
|
| 132944 |
Alamandine
|
|
decreases_activity of
|
inflammatory response
|
|
|
33169633
|
COVID-19
|
|
14,078
|
| 133026 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-9)
|
|
| 133027 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-7)
|
|
| 133028 |
ACE2
|
NOT |
decreases_quantity of
|
Bradykinin
|
|
| 133049 |
ACE2
|
|
decreases_quantity of
|
Apelin-13
|
|
| 133050 |
ACE2
|
|
decreases_quantity of
|
Apelin-36
|
|
|
32264791
|
COVID-19
|
|
14,109
|
| 133409 |
COVID-19
|
|
decreases_activity of
|
ACE2
|
|
|
33042994
|
COVID-19
|
|
14,273
|
| 134687 |
ACE2
|
|
decreases_quantity of
|
Angiotensin II
|
|
| 134688 |
ACE2
|
|
increases_quantity of
|
Angiotensin (1-7)
|
|
| 134689 |
ACE2
|
|
decreases_quantity of
|
Apelin
|
|
| 134690 |
ACE2
|
|
decreases_quantity of
|
Opioid
|
|
|
32208987
|
COVID-19
|
|
14,302
|
| 134951 |
ACE2
|
|
decreases_quantity of
|
Apelin-13
|
|
| 134952 |
ACE2
|
|
decreases_quantity of
|
Dynorphin A (1-13)
|
|
|
32305401
|
Cardiovascular disease
COVID-19
|
|
14,450
|
| 136361 |
Apelin
|
|
increases_activity of
|
APLNR
|
|
| 136362 |
Apelin
|
|
increases_activity of
|
vasodilation
|
|
| 136365 |
Apelin-13
|
|
increases_activity of
|
vasodilation
|
|
| 136366 |
Apelin-36
|
|
increases_activity of
|
vasodilation
|
|
|
23962453
|
SARS-CoV infection
|
CIDeRplus